PATIENT INFORMATION LEAFLET
|
|
- Roxanne Chambers
- 6 years ago
- Views:
Transcription
1 ZINCO-K 15 mg/5 ml syrup For oral use PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml syrup (1 spoon) contains 15 mg of zinc as zinc sulphate heptahydrate. Excipient(s): Sorbitol (%70), maltitol, citric acid monohydrate, methyl paraben, glycerin, orange flavor, sunset yellow (E110) and deionized water. Read this PATIENT INFORMATION LEAFLET carefully before you start using this medicine, because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. If you go to a doctor or hospital during the use of this medicine, inform your doctor about this Follow the instructions in this leaflet exactly. Do not use higher or lower doses than the dose which was recommended for you. What is in this leaflet: 1. What ZINCO-K is and what it is used for 2. Before you use ZINCO-K 3. How to use ZINCO-K 4. Possible side effects 5. How to store ZINCO-K 1. What ZINCO-K is and what it is used for? ZINCO-K is a zinc-containing syrup and presented in PET/PE spoons (each spoon (5 ml) contains 15 mg zinc as zinc sulfate heptahydrate) closed with aluminum. Each box contains 20 or 28 spoons of 5 ml capacity. The presentation of 20 spoons is also packaged in a PVC separator. It is used for the treatment or prevention of zinc deficiency 2. Before you use ZINCO-K Do not use ZINCO-K in the following conditions If; You are allergic (hypersensitivity) to zinc salts or any of the other ingredients of ZINCO-K TAKE SPECIAL CARE WITH ZINCO-K in the following conditions Since there is not adequate studies in those with kidney and liver disease please consult your doctor if you have any such disease. Accumulation of zinc in the body may increase in kidney failure, therefore caution should be exercised in cases of renal insufficiency. Prolonged use may cause copper deficiency.
2 Please consult your doctor, even if these statements were applicable to you at any time in the past. Using ZINCO-K with food and drink Since concomitant intake of zinc with high-fiber food, whole meal bread or dairy products decrease the absorption of zinc, ZINCO-K should not be taken together with these types of food. Also food rich in phytic acid (inositol) (e.g. wheat bran, flaxseed, cereals, legumes) and coffee may decrease the absorption of zinc compounds. In order to ensure maximum absorption, zinc salts should not be orally taken with foods and drinks (except for water). Pregnancy Ask your doctor or pharmacist for advice before taking the medicine. Use under the supervision of your doctor during pregnancy, if necessary. If you notice that you are pregnant during treatment, please consult your doctor or pharmacist immediately. Breastfeeding Ask your doctor or pharmacist for advice before taking the medicine. Use under the supervision of your doctor if necessary during breastfeeding. Effects on ability to drive and use machines No studies have been carried to test its effects on the ability to drive or use machines. Important information about some of the excipients of ZINCO-K If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking ZINCO-K, because it contains sorbitol and maltitol. It contains less than 10 g of glycerin per each dose of 5 ml. No adverse effects associated with glycerin are expected because of its dose This medicinal product contains methyl paraben which may cause allergic reactions (possibly delayed). This medicinal product contains sunset yellow (E110) which may cause allergic reactions. Using with other medicines Concomitant intake of zinc salts with tetracyclines (a type of antibiotic) or penicillamine (an antiinflammatory agent) may reduce the efficacy of zinc; therefore a 3-hour interval should be allowed between the intake of these agents and zinc. High dose iron preparations should not be taken with zinc, as they may reduce zinc absorption. Zinc may reduce the absorption of fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin, norfloxacin, and ofloxacin), a class of antibiotics used for the treatment of diseases caused by bacteria. Calcium salts may reduce zinc absorption. Contraceptives may reduce plasma zinc levels. Food rich in bran or fiber as well as dairy products may reduce zinc absorption.
3 Penicillamine and trientin (agents used for the treatment of excessive copper accumulation in the body, or Wilson s disease) may reduce zinc absorption; also zinc may reduce the absorption of these two agents. Antacids (agents reducing gastric acidity) may reduce the rate and extent of zinc sulfate absorption. Please tell your doctor or pharmacist if you are taking or have recently taken any other prescription or nonprescription medicine. 3. How to use ZINCO-K? Instructions for appropriate method and dose/frequency of administration: ZINCO-K can be used before, after, or during the meals in adults. Unless recommended otherwise by your doctor, use as specified below. Age Elementary zinc (mg) Tolerated dose (mg) 9-13 years years years adults Spoon Route and method of administration: ZINCO-K is only for oral use. Drink directly from the spoon. Different age groups: Use in children: Use in children is as described above. Use in elderly: The safety and efficacy of ZINCO-K in elderly have not been tested. Special populations: Kidney/liver failure: The safety and efficacy of ZINCO-K in patients with kidney or liver failure have not been tested. Accumulation of zinc in the body may increase in kidney failure, therefore caution should be exercised in cases of renal insufficiency. If you have the impression that the effect of ZINCO-K is too strong or too weak, talk to your doctor or pharmacist. If you have used more ZINCO-K than you should: If you may have taken more ZINCO-K than you should, talk to a doctor or pharmacist. In cases of overdose, symptoms such as low blood pressure, dizziness, drowsiness and vomiting may occur. If you forget to use ZINCO-K: Do not use a double dose to make up for a forgotten dose.
4 If you stop using ZINCO-K: Do not stop the treatment with ZINCO-K without consulting your doctor. 4. Possible side effects? Like all medicines, side effects can occur in people sensitive to the contents of ZINCO-K. Side effects are classified as follows: Very common (may be seen at least 1 in 10 patients) Common (may be seen less than one in 10 patients but more than one in 100 patients) Uncommon (may be seen less than one in 100 patients but more than one in 1000 patients) Rare (may be seen less than one in 1000 patients but more than one in patients) Very rare (may be seen less than one in patients) Unknown (it cannot be estimated from the available data). If any of the following occur stop using ZINCO-K and IMMEDIATELY inform your doctor or go to the nearest emergency department. Hypersensitivity reaction (difficulty in breathing and swallowing, swelling in the hands/feet, face/lips, rash, faintness etc.) These are all very serious side effects. If you have any of them, this means you have serious allergy to ZINCO-K. You may need emergency medical care or hospitalization. These very serious side effects occur very rarely. If you notice any of the following immediately inform your doctor or go to the nearest emergency department: Low blood pressure (hypotension), irregular heartbeat (arrhythmias) These are all serious side effects. They may require emergency medical treatment. These serious side effects occur very rarely. If you notice any of the following, inform your doctor: Vomiting Changes in blood count parameters (neutropenia, leukopenia, anemia) Nausea Abdominal pain Dyspepsia Headache Nervousness, drowsiness Paresthesia, Gastric sensitivity Inflammation of the gastric mucosa (gastritis) Dizziness Diarrhea These are mild effects of ZINCO-K. These side effects disappear when the dose is reduced or treatment is discontinued. If you notice any side effects not mentioned in this leaflet inform your doctor or pharmacist.
5 Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via clicking Reporting of Drug Side Effects icon on the website or Turkish Pharmacovigilance Center (TUFAM) by calling the phone number for side effects reporting line. By reporting side effects, you can help provide more information on the safety of this medicine. 5. How to store ZINCO-K Keep in the original package and out of the reach and sight of children. Store in room temperature under 25 C. Use in accordance with expiry date. Do not use ZINCO-K after the expiry date which is stated on the package. Do not use ZINCO-K if you notice any damage to the product and/or package. Marketing Authorization Holder: Berko İlaç ve Kimya San. A.Ş. Yenişehir Mah. Özgür Sok. No: Ataşehir/İstanbul (Pbx) (Fax) info@berko.com.tr Manufacturer: Berko İlaç ve Kimya San. A.Ş. Adil Mah. Yörükler Sok. No: 2 Sultanbeyli/İstanbul (Pbx) (Fax) This patient information leaflet was approved on 12/10/2016.
PATIENT INFORMATION LEAFLET
FERIFER-40 Oral Solution, 40 mg/5 ml For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each one spoon solution (5 ml) contains 40 mg of iron (as iron III polymaltose complex). Excipient(s):
More informationPATIENT INFORMATION LEAFLET
FERROZINC-G syrup, 100 ml For oral use PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml (1 spoon) syrup contains 40 mg iron (as ferrous gluconate) and 15 mg zinc (as zinc gluconate). Excipient(s):
More informationPATIENT INFORMATION LEAFLET
MAGNEZINC Film Coated Tablets For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each film tablet contains 30 mg zinc equivalent to 82.6 mg zinc sulfate monohydrate and 300 mg magnesium equivalent
More informationPATIENT INFORMATION LEAFLET
ALORES 2.5mg/5ml Syrup For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml syrup (1 spoon) contains desloratadine 2.5 mg. Excipient(s): Propylene glycol, sorbitol 70%, citric acid
More informationPATIENT INFORMATION LEAFLET
DROPOLEV 60 mg/ml oral drops, 30 ml For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 1 ml solution contains 60 mg levodropropizine. Excipient(s): Methyl paraben sodium, propylene glycol,
More informationPATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.
ALORES 2.5mg/5ml syrup For oral use only. PATIENT INFORMATION LEAFLET Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine. Excipients: Propylene glycol, sorbitol 70% (E420), citric
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% Nasal Spray For nasal use. PATIENT INFORMATION LEAFLET Active substance(s): Triamcinolone acetonide (w/w%) 0.055 Excipient(s): Benzalkonium chloride 50%, sodium hydroxide, hydrochloric acid,
More informationPATIENT INFORMATION LEAFLET
HAMAZINC cream For topical use. PATIENT INFORMATION LEAFLET Active substance(s): Each 1 gram cream contains 53.5 mg hamamelis virginiana distillate and 180.00 mg zinc oxide. Excipient(s): Methylparaben(E218),
More informationPATIENT INFORMATION LEAFLET
KLOBATE 0.05% cream For topical use. PATIENT INFORMATION LEAFLET Active substance(s): 0.05% clobetasol contains 17-propionate. Excipient(s): Stearyl alcohol, propylene glycol, vaseline, sorbitan sesquioleate,
More informationPATIENT INFORMATION LEAFLET
FERROZINC-G 40 mg/15 mg syrup For oral use PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml (1 spoon) syrup contains 344 mg iron II gluconate equivalent to 40 mg and 105 mg zinc gluconate equivalent
More informationPATIENT INFORMATION LEAFLET
HAMAZINC 5.35% + 18% cream For external use only. PATIENT INFORMATION LEAFLET Active substances: Each gram of cream contains; 53.5 mg hamamelis virginiana distillate and 180.00 mg zinc oxide. Excipients:
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET FERROZINC Capsules For oral use. Active substance(s): Each 1 capsule contains; 261.29 mg ferrous fumarate equivalent to 79.87 mg iron, 68.7 mg zinc sulfate monohydrate equivalent
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET BEVIT-B12 film tablet For oral use. Active substance: Each film-coated tablet contains 250 mg pyridoxine hydrochloride (Vitamin B 6 ), 250 mg thiamine hydrochloride (Vitamin
More informationPATIENT INFORMATION LEAFLET. Excipients: Sorbitol 70% (E420), glycerol, hydroxyethyl cellulose, mint flavor, purified water.
HEKSOBEN gargle For oral rinse PATIENT INFORMATION LEAFLET Active substance: 100 ml solution contains 120 mg (0.12%) chlorhexidine digluconate and 150 mg (0.15%) benzydamine hydrochloride. Excipients:
More informationPATIENT INFORMATION LEAFLET
DESIFEROL 2000 IU Film Coated Tablets For oral use only PATIENT INFORMATION LEAFLET Active substance(s): Each film coated tablet contains 2000 I.U. (50 ) vitamin D3 (derived from sheep wool). Excipient(s):
More informationPATIENT INFORMATION LEAFLET
N-CORT 0.055% nasal spray, suspension It is used by spraying into the nose. Active substance: (w/w%) Triamcinolone acetonide 0.055 PATIENT INFORMATION LEAFLET Excipients: Benzalkonium chloride 50%, sodium
More informationPATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate
PATIENT INFORMATION LEAFLET Calcichew* 500 mg Chewable Tablets calcium carbonate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationCa-C 1000 Calvive 1000 mg mg mg effervescent tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Ca-C 1000 Calvive 1000 mg + 327 mg + 1000 mg effervescent tablets CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE, ASCORBIC ACID (VITAMIN C) This leaflet is a copy
More informationDulcolax 5 mg, film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Dulcolax 5 mg, film-coated tablets BISACODYL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPATIENT INFORMATION LEAFLET EFFERFLU C IMMUNE BOOSTER. EFFERFLU C IMMUNE BOOSTER has not been evaluated by the Medicines Control
is an immune booster. has not been evaluated by the Medicines Control Council. is not intended to diagnose, treat, cure or prevent any disease. SCHEDULING STATUS: Not applicable PROPRIETARY NAME, STRENGTH
More information1. What Betahistine dihydrochloride tablets is and what it is used for
Package leaflet: Information for the user Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start
More informationBERAXIN is available in PVC-PE-PVDC/Aluminum blister packs of 7 film tablets containing 750 mg levofloxacin.
BERAXIN 750 mg Film Tablet For oral use PATIENT INFORMATION LEAFLET Active substance: Each film tablet contains 768.69 mg levofloxacin hemihydrate corresponding to 750 mg levofloxacin. Excipients: Microcrystalline
More informationPATIENT INFORMATION LEAFLET
ENFLUAT 0.4 % Sterile Eye Drops Applied dropwise to the eye. PATIENT INFORMATION LEAFLET Drug substance: Each 1ml contains 4 mg ketorolac tromethamine. Excipient(s): Benzalconium chloride, sodium chloride,
More informationPackage leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine
Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because
More informationBERLITHION 600 mg Capsule, soft
PACKAGE LEAFLET: INFORMATION FOR THE USER BERLITHION 600 mg Capsule, soft ALPHA LIPOIC (THIOCTIC ACID) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationPackage leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine
Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium
PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Kopen Sugar Free 125mg/5ml and 250mg/5ml Powder for Oral Solution Phenoxymethylpenicillin Read all of this leaflet carefully before you start taking this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)
PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone
PACKAGE LEAFLET PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES Lubiprostone This medicine is subject to additional monitoring. This will allow quick identification of new
More informationPATIENT INFORMATION LEAFLET TEXAMER
SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,
More informationPackage leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate
PACKAGE LEAFLET Package leaflet: Information for the patient Calcium Folinate 15 mg Tablets calcium folinate Read all of this leaflet carefully before you start taking this medicine because it contains
More informationFLUIMUKAN PLUS 600 mg effervescent tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER FLUIMUKAN PLUS 600 mg effervescent tablets Acetylcysteine This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets Read all of this leaflet carefully because it contains important
More informationPackage leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime
Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationRead all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Package leaflet: Information for the patient Megalac Hydrotalcite Chewable Tablets 500 mg Active substance: hydrotalcite Read all of this leaflet carefully before you start taking this medicine because
More informationWhat does this PIL contain?
PIL Paracetamol Amsal 120 mg / 5 ml Oral solution paracetamol Please, carefully read this PIL before you start using the medicine, because it contains very important information for you. -This medicine
More informationPackage leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)
Package leaflet: Information for the user Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)
PACKAGE LEAFLET: INFORMATION FOR THE USER 600 mg / 1,000 IU orodispersible tablets Calcium/cholecalciferol (Vitamin D3) Read all of this leaflet carefully before you start taking this medicine
More informationPROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.
SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need
More informationPackage leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide
Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPackage leaflet: Information for the patient. Megalac Almasilate 1 g/10 ml suspension. Active substance: almasilate
Package leaflet: Information for the patient Megalac Almasilate 1 g/10 ml suspension Active substance: almasilate Read all of this leaflet carefully before you start taking this medicine because it contains
More information1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You
More informationPACKAGE LEAFLET DIASTABOL 50 MG TABLETS. Version 1.0 1
PACKAGE LEAFLET DIASTABOL 50 MG TABLETS 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Diastabol 50 mg tablets miglitol Read all of this leaflet carefully before you start taking this medicine. - Keep this
More informationHERNOVIR 200 mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPackage leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000
Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000
More informationPackage leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)
Package leaflet: Information for the user Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base) Read all of this leaflet carefully before you start taking this medicine because
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Vasexten 10, 10 mg modified release capsules Vasexten 20, 20 mg modified release capsules barnidipine hydrochloride Read all of this leaflet
More informationPATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:
SCHEDULING STATUS: S2 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: TEXA 10 mg (tablets) TEXA SYRUP (syrup) Read this entire leaflet carefully before you start taking TEXA. Keep this leaflet. You
More informationPackage leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)
Package leaflet: Information for the patient Loratadine 10 mg Tablets (loratadine) Read all of this leaflet carefully before you start taking this medicine because it contains important information for
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate) Pfizer Logo Read all of this leaflet carefully before you start taking this
More informationZofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.
Package Leaflet: Information for the User Zofran 4 mg/5 ml Syrup Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationTOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate
TOULARYNX DEXTROMETHORPHAN FORTE 3 mg/ml, syrup Dextromethorphan HBr monohydrate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPATIENT INFORMATION LEAFLET
IBU-FORT 200 mg/5 ml suspension, 100 ml For oral use. PATIENT INFORMATION LEAFLET Active substance(s): Each 5 ml (1 measuring cup) suspension contains 200 mg ibuprofen. Excipient(s): Xanthan gum, hydroxypropyl
More informationPackage leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)
Package leaflet: Information for the patient Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride) Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the user
Package leaflet: Information for the user Irbesartan 75mg Film-coated Tablets Irbesartan 150mg Film-coated Tablets Irbesartan 300mg Film-coated Tablets irbesartan Read all of this leaflet carefully before
More informationPackage leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride
Package leaflet: Information for the patient / / 30 mg/5 ml syrup Ambroxol hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationERGOMETRIN Lek 0.2 mg film-coated tablet
PACKAGE LEAFLET: INFORMATION FOR THE USER ERGOMETRIN Lek 0.2 mg film-coated tablet ERGOMETRINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPackage leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000
Package leaflet: Information for the user Omnilax 10 g powder for oral solution, sachet Macrogol 4000 Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPackage leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride
Package leaflet: Information for the user Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for users. Imodium 2 mg orodispersible tablets Loperamide hydrochloride
MARKETING AUTHORISATION NO. 7810/2015/01-02-03-04 Annex 1 Package leaflet Package leaflet: Information for users Imodium 2 mg orodispersible tablets Loperamide hydrochloride Read all of this leaflet carefully
More informationPackage leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline
Package leaflet: Information for the patient Lymelysal 300 mg hard capsules lymecycline equivalent to 300 mg tetracycline Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the user. Ursodeoxycholic Acid Capsules 250mg (Ursodeoxycholic acid)
Package leaflet: Information for the user Ursodeoxycholic Acid Capsules 250mg (Ursodeoxycholic acid) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationDialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride
PACKAGE LEAFLET: INFORMATION FOR THE USER Dialosa 1 mg, 2 mg, 3 mg, 4 mg and 6 mg tablets Glimepiride Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may
More informationPackage leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide
Package leaflet: Information for the patient Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide This medicine is subject to additional monitoring. This will allow quick identification of
More informationImodium 1 mg/5 ml oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Imodium 1 mg/5 ml oral solution Loperamide hydrochloride Imodium is a registered trademark Read all of this leaflet carefully before you start using this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Aspecton Cough Syrup. Thyme soft extract. For adults and children aged 1 year and older
PACKAGE LEAFLET: INFORMATION FOR THE USER Aspecton Cough Syrup Thyme soft extract For adults and children aged 1 year and older Read all of this leaflet carefully before you start taking this medicine
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride
PACKAGE LEAFLET: INFORMATION FOR THE USER SALAGEN 5 mg film-coated tablets Pilocarpine hydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)
PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read
More informationPackage leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )
Package leaflet: Information for the user Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 ) For medicinal products available on prescription only: Read all of this
More informationPackage leaflet: Information for the User Clarityn 10 mg tablets Loratadine
Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always
More informationFlavamed Forte 30 mg/5 ml, oral solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Flavamed Forte 30 mg/5 ml, oral solution AMBROXOL HYDROCHLORIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet
More informationPackage leaflet: Information for the user. Calcichew-D 3 Citron 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )
Package leaflet: Information for the user Calcichew-D 3 Citron 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 ) For medicinal products available on prescription only: Read all of
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE
PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to
More informationLIPOFEN SR 250 mg CAPSULE, HARD
PACKAGE LEAFLET: INFORMATION FOR THE USER LIPOFEN SR 250 mg CAPSULE, HARD FENOFIBRATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which
More informationPyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.
PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Pyrazinamide 500 mg Tablets * Pyrazinamide Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.
More informationPackage leaflet: Information for the user. ELEVIT PRONATAL film-coated tablets 12 vitamins and 7 minerals and trace elements
Package leaflet: Information for the user ELEVIT PRONATAL film-coated tablets 12 vitamins and 7 minerals and trace elements Read all of this leaflet carefully before you start taking this medicine because
More informationPackage leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone
Package leaflet: Information for the patient Dexametason Abcur 1 mg tablets Dexametason Abcur 4 mg tablets Dexamethasone Read all of this leaflet carefully before you start taking this medicine because
More informationPATIENT INFORMATION LEAFLET
PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Closerine * Cycloserine 250 mg capsules Read all of this leaflet carefully before you start taking this medicine
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET page 1 of 5 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER ZinCfant 20mg * Zinc (as sulfate monohydrate) 20 mg tablet Read all of this leaflet carefully before you start
More informationWHOPAR Part 3 March Zinc (as sulfate monohydrate) 20 mg Tablets (Macleods Pharmaceuticals Ltd), DI005 PACKAGE LEAFLET.
PACKAGE LEAFLET Page 1 of 5 PACKAGE LEAFLET: INFORMATION FOR THE USER Zinc (as sulfate) Dispersible Tablets 20 mg* Zinc (as sulfate monohydrate) 20 mg Tablets Read all of this leaflet carefully before
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)
PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate) Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Artefan 20/120 * artemether/lumefantrine 20mg/120mg tablets Read all of this leaflet carefully before you start
More informationPACKAGE LEAFLET: Information for the user. METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride)
PACKAGE LEAFLET: Information for the user METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride) Read this leaflet carefully before you start taking this medicine. - Keep this
More informationRANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information
More informationSPASMEX FORTE 5mg tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER SPASMEX FORTE 5mg tablets TROSPIUM This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationPackage leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine
Package leaflet: Information for the patient Histaclar 10 mg Film-coated Tablets loratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPackage leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine
Package leaflet: Information for the patient Felodipin AstraZeneca 2.5 mg prolonged-release tablets Felodipin AstraZeneca 5 mg prolonged-release tablets Felodipin AstraZeneca 10 mg prolonged-release tablets
More informationPATIENT INFORMATION LEAFLET TREGS
PATIENT INFORMATION LEAFLET TREGS 1 g IM powder for injection For intramuscular use. Active ingredient: Each vial contains: 1000 mg ceftriaxone as 1192.89 mg ceftriaxone sodium. Each ampoule contains:
More informationPackage leaflet: Information for the patient. Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin
Package leaflet: Information for the patient Clarithromycin Kern Pharma 500 film-coated tablets Clarithromycin Read all of this leaflet carefully before you start taking this medicine because it contains
More informationPACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
More informationPackage leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection
PACKAGE LEAFLET 1 Package leaflet: Information for the patient ERWINASE 10,000 Units, Powder for solution for injection (Asparaginase from Erwinia chrysanthemi; Erwinia L-asparaginase) Read all of this
More informationPackage Leaflet: Information for the patient. FERROUS SULFATE TABLETS 200 mg Ferrous Sulfate
Package Leaflet: Information for the patient FERROUS SULFATE TABLETS 200 mg Ferrous Sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER
PACKAGE LEAFLET: INFORMATION FOR THE USER Calcium Sandoz 500 mg, effervescent tablets Calcium Sandoz 1000 mg, effervescent tablets Calcium Read all of this leaflet carefully because it contains important
More informationPackage leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)
Package leaflet: Information for the user Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate) Read all of this leaflet carefully before you start taking this medicine because
More information